Survival of
patients with lymphoproliferative diseases increases.
For effective treatment we should
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019) in
patients with massive PE. Study aim: We aimed to share the results of
thrombolytic treatment in
patients deformity disorder is more severe in
patients with CHF of III-IV functional classes [Mondillo S. et al, 2011].
years, most
patients develop severe side effects such as dyskinesias and motor fluctuations after
meteorological effects, decrease in specific and non-specific factors for protecting the oral cavity, the
patientYunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) efficacy of
patients with multidrug-resistant (MDR), extensively drug-resistant (XDR) and drug
REPLICATIVE STUDY OF GWAS-ASSOCIATED CANDIDATE GENE LOCI IN
PATIENTS WITH OSTEOARTHRITIS FROM